Retrospective review of experience with sarcomatoid renal cell carcinoma: Multimodality treatment remains an unmet goal

Conclusion: The current adjuvant chemotherapy used in sRCC patients who develop metastasis gives no survival advantage.

Source: Urology Annals - October 8, 2019 Category: Urology & Nephrology Authors: Gowrinath Kondisetty Pallavi Vijay Borkar Sandeep Kondisetty Appu Thomas Source Type: research